ZEVRA THERAPEUTICS, INC.

Nasdaq:ZVRA

Pharmaceutical Preparations·BOSTON, MA

CEO

Mcfarlane Neil F.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/9/26	→
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/12/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
↓

Earnings Releases (8-K)

24 shown

Filed	Period
3/9/26	Q1 FY2026	→
11/5/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
4/7/25	Q1 FY2025	→
3/11/25	Q1 FY2025	→
↓

News (8-K)

56 shown

Filed	Type	Description
12/17/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/2/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/20/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
5/29/25	Vote	Submission of Matters to a Vote of Security Holders	→
2/27/25	Agreement	Entry into a Material Definitive Agreement	→
12/6/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
3/9/26	S-8	S-8	→
3/13/25	S-8	S-8	→
8/9/24	424B5	424B5	→
8/8/24	424B5	424B5	→
7/12/24	424B2	424B2	→
6/4/24	S-3	S-3	→
↓

Filing History(834 filings)

TypeDateAccessionPeriodSize

S-8

Mar 9, 2026

0001434647-26-000013S-8

—

258.4 KB

10-K

Mar 9, 2026

0001434647-26-00001110-K

Dec 31, 2025

10.5 MB

8-K

Mar 9, 2026

0001434647-26-0000098-K

Mar 4, 2026

590.7 KB

Feb 10, 2026

0001681098-26-000004FORM 4

Feb 7, 2026

9.0 KB

Feb 4, 2026

0001698328-26-000004FORM 4

Feb 3, 2026

5.2 KB

Feb 4, 2026

0001945557-26-000004FORM 4

Feb 3, 2026

5.2 KB

Feb 2, 2026

0001698328-26-000002FORM 4

Jan 30, 2026

12.5 KB

Feb 2, 2026

0001788524-26-000002FORM 4

Jan 29, 2026

13.6 KB

Feb 2, 2026

0001910132-26-000002FORM 4

Jan 29, 2026

13.6 KB

Feb 2, 2026

0001945557-26-000002FORM 4

Jan 29, 2026

17.2 KB

Feb 2, 2026

0001681098-26-000002FORM 4

Jan 29, 2026

13.6 KB

144

Feb 2, 2026

0001950047-26-000828

—

5.1 KB

144

Jan 30, 2026

0001950047-26-000775

—

5.0 KB

144

Jan 30, 2026

0001950047-26-000773

—

5.0 KB

144

Jan 30, 2026

0001950047-26-000771

—

4.9 KB

144

Jan 30, 2026

0001950047-26-000770

—

5.0 KB

144

Jan 30, 2026

0001950047-26-000769

—

4.8 KB

Jan 7, 2026

0001488774-26-000002FORM 4

Dec 31, 2025

12.6 KB

8-K

Dec 17, 2025

0001434647-25-0000188-K

Dec 11, 2025

138.6 KB

Dec 9, 2025

0001584516-25-000009FORM 4

Dec 2, 2025

5.8 KB

Dec 9, 2025

0001584516-25-000007FORM 3

Dec 2, 2025

403.5 KB

8-K

Dec 2, 2025

0001434647-25-0000158-K

Nov 26, 2025

168.6 KB

8-K

Nov 20, 2025

0001193125-25-2898658-K

Nov 20, 2025

155.4 KB

SCHEDULE 13G/A

Nov 14, 2025

0000902664-25-005021

—

8.9 KB

SCHEDULE 13G/A

Nov 13, 2025

0000902664-25-004878

—

12.3 KB

25 filings shown

Filed	Form	Description
5/21/25	DEFA14A	DEFA14A	→
5/8/25	DEFA14A	DEFA14A	→
4/29/25	DEFC14A	DEFC14A	→
4/21/25	DEFA14A	DEFA14A	→
4/21/25	DEFA14A	DEFA14A	→
4/21/25	DEFC14A	DEFC14A	→
↓

ZEVRA THERAPEUTICS, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(834 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/10/26	4	4	→
2/4/26	4	4	→
2/4/26	4	4	→
2/2/26	4	4	→
2/2/26	4	4	→
2/2/26	4	4	→
↓

Filed	Form	Description
2/2/26	144	144	→
1/30/26	144	144	→
1/30/26	144	144	→
1/30/26	144	144	→
1/30/26	144	144	→
1/30/26	144	144	→
↓